Listed

Sunshine Biopharma Inc.: Form 10-Q for the period ended Mar 31, 2011

Filed with the SEC on May 12, 2011 and accepted by EDGAR at May 12, 2011, 14:20 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2011-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2011-01-01 to 2011-03-31$0us-gaap:SalesRevenueGoodsNet
Research and development3 months2011-01-01 to 2011-03-31$17.6kus-gaap:ResearchAndDevelopmentExpense
Net income3 months2011-01-01 to 2011-03-31−$49.2kus-gaap:NetIncomeLoss
Basic EPS3 months2011-01-01 to 2011-03-31−$0.00us-gaap:EarningsPerShareBasic
Operating cash flow3 months2011-01-01 to 2011-03-31−$44.3kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2011-03-31$118.1kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2011-03-31$159.3kus-gaap:AssetsCurrent
Total assetsAt period end2011-03-31$159.3kus-gaap:Assets
Total liabilitiesAt period end2011-03-31$330us-gaap:Liabilities

Source: SEC EDGAR, the filing index for accession 0001354488-11-001463. Last ingested by Listed: Nov 14, 2026, 19:46 ET. Listed shows no prices and gives no investment advice.